findmyKOL
Clinical trialNCT00006398CompletedPhase 3Interventional

Prevention of Esophageal Varices by Beta-Adrenergic Blockers

SponsorNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Enrollment213Esophageal and Gastric VaricesLiver CirrhosisPortal Hypertension
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of this study is to learn whether timolol is useful in preventing or delaying the appearance of gastroesophageal varices, a complication that may develop in the future as a consequence of liver disease. Cirrhosis causes an increased resistance of blood flowing through the liver. This leads to an increased pressure in the portal vein (the vein that takes blood to your liver). High portal pressure is responsible for the appearance of complications of chronic liver disease such as varices and variceal bleeding (bleeding from veins in your esophagus). Timolol belongs to a group of medications called beta-blockers. Beta-blockers decrease high portal pressure and previous studies have shown that beta-blocker pills are useful in preventing bleeding from varices in patients who already have varices. A more desirable effect would be if these pills could prevent not only bleeding from varices but the appearance of varices (and therefore of bleeding).

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

5 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Spain
  • Hospital Clinic I Provincial de Barcelona

    Barcelona, Catalonia, Spain

United Kingdom
  • Royal Free Hospital

    Hampstead, London, United Kingdom

United States
  • Yale University Sch. of Medicine

    New Haven, Connecticut, United States

  • Va Ct Healthcare System

    West Haven, Connecticut, United States

  • the Faulkner Hospital

    Boston, Massachusetts, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Aug 1993
Primary completion
30 Sept 2002
Completion
30 Sept 2002
Last update posted
1 Jun 2017
Registered enrollment
213
Registry id
NCT00006398

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.